Obstruction caused by excessively accumulated mucin in the inflamed gallbladder has been suspected to be the source of biliary pain [27], so therapy for chronic cholecystitis through decreasing mucin secretion by COX-2 inhibitors seems promising. This evidence concerns the gene MUC5AC and Cholecystitis.